Related Experiment Video
Updated: Aug 5, 2026

Transcranial Direct Current Stimulation for Online Gamers
Published on: November 9, 2019
Tobacco use and gambling disorder: Associations with clinical characteristics, and treatment outcome
Gemma Mestre-Bach1, Bibiana Badiella2, Guillem Diego Esteve3
1Grupo de Investigación en Adicciones Comportamentales (GIAC), Universidad Internacional de La Rioja, La Rioja, Spain; Psychoneurobiology of Eating and Addictive Behaviors Group, Neuroscience Program, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain; Ciber Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III, Barcelona, Spain.
Background And Aims:
Gambling disorder (GD) usually co-occurs with other addictive behaviors. Given shared neurobiological underpinnings, particularly involving dopaminergic pathways, and behavioral similarities such as high reward sensitivity, investigating the link between GD and tobacco use is warranted. Therefore, the present study explored how daily smoking use relates to clinical, personality, and psychopathological profiles, as well as its potential association with treatment outcomes.
Methods:
Our sample included 455 individuals with GD, who completed clinical, personality, psychopathology, impulsivity, and emotion regulation assessments before undergoing a 16-week group cognitive behavioral therapy. Patients were categorized as smokers (daily smokers of conventional cigarettes) or non-smokers to examine differences in clinical profiles and treatment outcomes, specifically dropouts and relapses.
Results:
While no significant differences emerged in overall psychopathology, personality, or emotion regulation, daily tobacco users with GD exhibited higher levels of impulsivity. Trends toward increased treatment dropout and relapse were observed, though these did not reach statistical significance.
Discussion And Conclusion:
These findings suggest that while daily tobacco use in GD is associated with heightened impulsivity, its impact on overall clinical profiles may be limited. However, the observed trend toward poorer treatment outcomes warrants further investigation, particularly focusing on interventions targeting impulsivity in populations with co-occurrent disorders.
Related Concept Videos
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Diagnostic and Statistical Manual of Mental Disorders (DSM)
CNS Depressants: Alcohol and Nicotine
Drug Dependence
Drug Abuse and Addiction: Pharmacological Phenomena
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...